UCB SA - Company Profile
Powered by 
All the data and insights you need on UCB SA in one report.
$295
- Save hours of research time and resources with
our up-to-date UCB SA Strategy Report
- Understand UCB SA position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Related keylists
The following section provides information on UCB SA’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into UCB SA's management and employees, unlock the full data with our company analytics monitoring tool.
Executives
Jonathan Peacock
Chairman Executive BoardMr. Jonathan Peacock has been the Chairman of the company since March 2023. He serves as a Director of the company since 2021. Prior to this he served as a Chairman from 2014- 2021 and Chief Executive Officer from 2014-2016 at Bellerophon Therapeutics, Inc. Previously he served as a Chairman of Arix Bioscience plc from 2016-2020.
Fiona du Monceau
Vice Chairwoman Executive BoardMs. Monceau has been the Vice Chairwoman of the company since 2023. She also served as the Interim Chairman of the company and GNCC. Prior to this, she served as a Chief Operating Officer of ExeVir Bio.
Jean-Christophe Tellier
Chief Executive Officer Senior ManagementMr. Jean-Christophe Tellier has been the Chief Executive Officer of the company since 2014. Prior to this, he was the Executive Vice President of BioBrands and Solutions division of the company. Currently, he also serves as the Member of the Board of the European Federation of Pharmaceutical Industries and Associations (EFPIA), Vice Chairman of the Innovation Board Sponsored Committee (EFPIA), President of International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) and Chairman of the BCR.
Sandrine Dufour
Chief Financial Officer; Executive Vice President Senior ManagementMs. Sandrine Dufour has been the Executive Vice President, and Chief Financial Officer of the company since July 2020. Prior to this role, she served as Chief Financial Officer at Proximus. Previously, she served as Executive Vice President of Innovation and Deputy Chief Financial Officer of Vivendi and Executive Vice President of Finance and Strategy at SFR.
Iris Low-Friedrich, M.D.
Chief Medical Officer; Executive Vice President - Global Projects and Development Senior ManagementDr. Iris Low-Friedrich has been the Executive Vice President and the Chief Medical Officer of the company since 2008. Prior to this, she was the Head of Research and Development of Schwarz Pharma AG. Ms. Friedrich also served on the Executive Board of Schwarz Pharma AG, and Vice President and Head of Global Projects at BASF Pharma.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer